‘We lost quite a bit of money’
May 4, 2024
The future of business is here. The fusion of human and AI capabilities will revolutionize how customers and organizations interact; the ...
BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes ...
© Reuters. FILE PHOTO: Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken, May ...
The US government lab that last year reached a long-sought milestone in nuclear fusion — achieving a controlled reaction that ...
Accelerator program Fusion announced today the final closing of its $20 million fund for investment in pre-seed startups built ...
Israeli nuclear fusion energy company NT-Tao today announced the completion of a $22 million Series A financing round led ...